Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2017Cancer Biotherapy and Radiopharmaceuticals

Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: Review of Safety, Response Evaluation Criteria in Solid Tumors 1.1 Imaging Response and Survival

View Full Paper
Ask AI
Bookmark
Share

Authors

NSNathaniel SwinburneMemorial Sloan Kettering Cancer CenterDBD. BiedermanYale UniversityCBCecilia BesaPontificia Universidad Católica de Chile

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Swinburne et al. (2017) studied this question.

synapsesocial.com/papers/6ab0dcbc0fb9fae1cec5a390https://doi.org/10.1089/cbr.2017.2189
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma2003 · 453 citations
  2. 2Increasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United States2001 · 1,011 citations
  3. 3Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysis2014 · 189 citations